Diabetes

Is Embecta Back on Track After a Tough Year?Is Embecta Back on Track After a Tough Year?

A medtech analyst shares why Embecta is now heading in the right direction.

Jan 16, 2025

|

1 Min Read

Wearable Medical Devices

Packaging Lessons Learned from the First FDA-Cleared OTC Continuous Glucose Monitors Packaging Lessons Learned from the First FDA-Cleared OTC Continuous Glucose Monitors

byLisette Hilton

Jan 10, 2025

1 Min Read

What’s Top of Mind for Medtech Heading into 2025?What’s Top of Mind for Medtech Heading into 2025?

byAmanda Pedersen

Dec 5, 2024

5 Slides

continuous glucose monitor

Glucotrack Begins Enrollment for Long-term Implantable CGM Study Glucotrack Begins Enrollment for Long-term Implantable CGM Study

byKatie Hobbins

Dec 3, 2024

1 Min Read

doctor checks patient's continuous glucose monitor

Biggest Trends in the Diabetes Tech Market Biggest Trends in the Diabetes Tech Market

byLisette Hilton

Nov 30, 2024

1 Min Read

Embecta Pumps the Brakes on Insulin Patch Pump Program Embecta Pumps the Brakes on Insulin Patch Pump Program

Nov 26, 2024

1 Min Read

Dexcom Finds New Partner in Oura Smart

Dexcom Finds New Partner in Oura Smart

product image of an Eversense 365 CGM sensor and a smartphone displaying the accompanying app.

Eversense 365 Could Change the CGM Game ... If Senseonics Doesn't Fumble the Execution

Execution Is Critical for World's First Year-Long CGM

byAmanda Pedersen

Dexcom Stelo

Dexcom Stock Tanks Despite Beating Q324 Estimates

Dexcom Stock Tanks Despite Beating Q324 Estimates

byKatie Hobbins, Managing Editor

Medtronic MiniMed 600 and 700 Series Pumps

Regulatory & Quality

Medtronic MiniMed 600 and 700 Series Pump Recall Dubbed FDA Class I

Medtronic MiniMed 600 and 700 Series Pump Recall Dubbed FDA Class I

byKatie Hobbins, Managing Editor

Abbott Laboratories

Abbott Lifts Annual Profit Forecast, Banks on CGM Sales

Abbott Lifts Annual Profit Forecast, Banks on CGM Sales

byKatie Hobbins, Managing Editor

Taking the Pulse of the Medical Device Industry

Taking the Pulse of the Medical Device Industry

Senseonics Wins FDA Clearance for Year-Long CGM

Senseonics Wins FDA Clearance for Year-Long CGM

injection mold

Innovative Mold for Cleanroom Production of Insulin Pen Housings Showcased at Fakuma

Innovative Mold for Cleanroom Production of Insulin Pen Housings Showcased at Fakuma

byNorbert Sparrow

FreeStyle Libre 3

Regulatory & Quality

Abbott FreeStyle Libre 3 CGM Recall Designated Class I

Abbott FreeStyle Libre 3 CGM Recall Designated Class I

byKatie Hobbins, Managing Editor

Abbott Launches OTC Continuous Glucose Monitor

Abbott Launches OTC Continuous Glucose Monitor

Abbott Goes 'Bionic' in Latest Diabetes Tech Collaboration

Abbott Goes Bionic in Latest Diabetes Tech Collaboration

The Clearances & Approvals Keep Coming in Diabetes Tech

The Clearances & Approvals Keep Coming in Diabetes Tech

Insulet Keeps Diabetes Tech Thriving with New Clearance

Insulet Keeps Diabetes Tech Thriving with New Clearance

Dexcom Launches the Next Phase in Evolution for CGMs

Dexcom Launches the Next Phase in Evolution for CGMs

Graphic featuring visuals of 5 hot topics in medtech for the month of August 2024

5 Things Medtech Is Talking About in August

5 Things Medtech Is Talking About in August

byAmanda Pedersen

Senseonics Looks to Stand Apart from the Big 3 in Diabetes Tech

Senseonics Looks to Stand Apart from the Big 3 in Diabetes Tech

Graphic for Pedersen's POV, a weekly medtech opinion column written by MD+DI Senior Editor Amanda Pedersen

Embracing the Olympic Spirit in Medtech and Beyond

Embracing the Olympic Spirit in Medtech and Beyond

byAmanda Pedersen

What Abbott & Medtronic's Collaboration Means for Diabetes Tech

Abbott & Medtronic Form ‘Surprising’ Partnership in CGM Space

Paris Olympics

Why are Non-Diabetic Olympic Athletes Using CGMs?

Why are Non-Diabetic Olympic Athletes Using CGMs?

byKatie Hobbins, Managing Editor

Dexcom’s Not-So-Flattering Earnings Results

Dexcom’s Not-So-Flattering Earnings Results

Abbott Laboratories

Regulatory & Quality

Abbott Recall Small Number of FreeStyle Libre 3 Sensors

Abbott Recall Small Number of FreeStyle Libre 3 Sensors

byKatie Hobbins, Managing Editor

Photo of four orange-capped syringes for insulin injection/diabetes management, shown against a pink background

Embecta M&A Rumor Not Surprising

Embecta M&A Rumor Not Surprising

byAmanda Pedersen

cleanroom manufacturing

Japan’s Nipro Medical Chooses North Carolina for First North American Production Plant

Japan’s Nipro Medical Chooses North Carolina for First North American Production Plant

Dexcom

Dexcom to Axe 535 Employees at San Diego HQ

Dexcom to Axe 535 Employees at San Diego HQ

byKatie Hobbins, Managing Editor

Sponsored Content

Micro Manufacturing for Wearable Diabetes Devices: Thin Wall & Overmolding Case Study

Micro Manufacturing for Wearable Diabetes Devices: Thin Wall & Overmolding Case Study

Sponsored Content

Transforming Glucose Monitoring: A Deep Dive into CGM Technologies and Their Role in Modern Diabetes Management

Transforming Glucose Monitoring: A Deep Dive into CGM Technologies and Their Role in Modern Diabetes Management

Sponsored Content

Relieving the Burden: Innovative Diabetes Solutions

Relieving the Burden: Innovative Diabetes Solutions

Omnipod 5

Insulet Reports Positive Type 2 Diabetes Study Results

Insulet Reports Positive Type 2 Diabetes Study Results

byKatie Hobbins, Managing Editor

Diabetes testing strips

Roche Sues Sellers Over Counterfeit Diabetes Products Sold on Amazon

Roche Sues Sellers Over Counterfeit Diabetes Products Sold on Amazon

byKatie Hobbins, Managing Editor

Sign up for the QMED & MD+DI Daily newsletter.